Now I have a thorough understanding of the paper. Let me synthesize the final review.

## Final Review

## Summary
This paper proposes a three-stage pipeline for the cold-start problem in biomedical image classification: (i) self-supervised pretraining (SimCLR) to build a meaningful latent space, (ii) furthest-point sampling (FPS) to select informative points for annotation from that latent space, and (iii) model soups to train the classifier head without a validation set. Experiments on four biomedical datasets compare FPS against random sampling and the prior state-of-the-art Cold PAWS.

---

## Strengths

- **Competitive results on most datasets**: The framework achieves the highest F1-macro on three of four biomedical datasets (Matek, ISIC, Retinopathy) when compared to random sampling and the sampling component of Cold PAWS, with consistent gains especially on the imbalanced Matek dataset (Table 1).

- **Substantial computational speedup**: FPS sampling is considerably faster than Cold PAWS across all datasets (Table 3) — the complexity advantage of O(nm) over O(n²m) is clear, and this translates into wall-clock time savings of 5× or more.

- **Ablation studies support the design choices**: The paper systematically ablates SSL methods (SimCLR > SwAV, DINO for budget=100, Figure 5), sampling strategies (FPS consistently beats k-means variants, Figure 4), and the model soups technique (Figure 6), confirming that each component contributes positively.

- **Class coverage analysis provides mechanistic insight**: Table 2 shows that FPS achieves better class coverage than alternatives, offering a plausible explanation for why it tends to perform better on imbalanced biomedical data.

---

## Weaknesses

### Fatal
None.

### Major

- **Unfair/incomplete comparison with the state-of-the-art (Cold PAWS).** The paper removes Cold PAWS's semi-supervised learning (FixMatch) component, stating this ensures a "fair comparison between models designed to accommodate unlabeled data and those that do not" (Section 4.2). This is a methodological choice that the authors defend, but it creates a problem: Cold PAWS is a complete system whose contribution includes both the sampling method *and* the subsequent semi-supervised training. By disabling the latter, the paper compares a partial pipeline against a full pipeline of a different type. The central claim that the proposed approach "outperforms the state-of-the-art" is therefore unsupported — what is actually shown is that FPS sampling + supervised training beats Cold PAWS sampling + supervised training. Authors should additionally compare FPS + supervised training against the *full* Cold PAWS pipeline (including FixMatch) to demonstrate that the proposed framework is genuinely competitive with the complete system it claims to surpass.

### Minor

- **Inconsistent speedup claim.** The abstract states "8 times faster performance" on the leukemia (Matek) task, but the main text (Section 4.3, Table 3 caption) says "FPS is five times faster than this state-of-the-art." These numbers are inconsistent. The authors should either correct the abstract to match the reported 5× figure or clarify the calculation basis for 8×.

- **Unsubstantiated claim about Cold PAWS information leakage.** The paper states that "Cold paws utilizes the testing dataset for early stopping, potentially introducing information leakage into their results" (Section 4.3). This is a specific methodological accusation against a peer publication, but no citation, reference to the original paper, or experimental evidence is provided to support it. Such a claim requires substantiation; without it, it reads as an unsupported dismissal.

- **Failure analysis for the Jurkat dataset is missing.** FPS is not the best-performing method on Jurkat (Table 1 shows closest/farthest with k=50 performs best). The paper acknowledges this fact but provides no analysis of *why* Jurkat deviates from the pattern observed on the other three datasets. Since Jurkat is the largest dataset and the only one involving flow cytometry images, understanding this exception would help define the scope of where FPS works and where it might not.

### Trivial
- None that survive filtering.

---

## Nice-to-Haves

- **Statistical significance testing.** The paper reports means and standard deviations over five random seeds but does not run paired significance tests (e.g., Wilcoxon signed-rank) to confirm that the improvements over random and Cold PAWS are unlikely by chance. This would strengthen the claims.

- **Ablation of SSL necessity.** Showing results when FPS is applied to a randomly initialized encoder (without SSL pretraining) would clarify whether the pretraining step is truly necessary for FPS's effectiveness or whether FPS alone drives the gains.

---

## Removed Points

These points are flagged to be removed; treat them with caution:

- **Missing results for annotation budgets of 200 and 500.** The paper states "We conduct similar experiments on bigger annotation budget (200, and 500 images)" (Section 4.3). These results are likely in the appendix, which is stripped by the parser. Per the meta-review rules, criticisms about missing appendix content are removed. *(Rationale: parser strips appendices from all submissions; the results exist in the original.)*

- **Criticism that the paper does not state code release plans.** Per the meta-review rules, this is a reproducibility nitpick about an artifact impractical to assess within the submission format. *(Rationale: soft reproducibility concern, not a structural flaw.)*

- **Criticism that the paper should also cover additional domains/tasks.** Demands for broader scope outside the paper's stated biomedical focus are removed as scope creep. *(Rationale: the paper is scoped to biomedical image classification; evaluating it against a broader canvas is not a valid weakness.)*

- **Criticism that the k-means closest-to-centroid baseline is weak.** The paper already finds this method performs poorly; including it as a baseline does not harm the contribution, it simply establishes a lower bound. *(Rationale: having weaker baselines does not invalidate the core result.)*

- **Criticism that hyperparameters for SwAV/DINO were not tuned for biomedical data.** The paper acknowledges this limitation ("We apply the original training configurations") and uses these methods mainly to show that SimCLR is the more suitable SSL method for this setting. The comparison is informative even without per-dataset tuning. *(Rationale: the paper's own experiments adequately contextualize this limitation.)*

---

## Novel Insights

None beyond the paper's own contributions. The reviews confirm the paper's core empirical findings (FPS + SimCLR works well on biomedical cold-start) but do not surface any deeper theoretical insight, new problem formulation, or unexpected phenomenon that was latent in the paper.

---

## Suggestions

1. **Fix the comparison with Cold PAWS:** Either (a) run the full Cold PAWS pipeline (including FixMatch) on the same biomedical datasets and report results, or (b) revise claims from "outperforms the state-of-the-art" to "outperforms the state-of-the-art sampling strategy under supervised training." The current framing overreaches the evidence.
2. **Resolve the 8× vs. 5× inconsistency** in the abstract and ensure all quantitative claims are traceable to specific tables.
3. **Provide evidence or remove the information leakage accusation** against Cold PAWS. Unsupported methodological criticisms weaken the paper's scholarly tone.
4. **Add a brief analysis of the Jurkat exception** — even a paragraph speculating on why FPS underperforms (e.g., latent space structure, homogeneity of samples) would strengthen the paper's contribution by defining the method's scope.
5. **Add significance tests** (e.g., Wilcoxon) over the five seeds to quantify confidence in the reported improvements.

---

## Score and Decision

The paper addresses a practically important problem and assembles off-the-shelf components (SimCLR, FPS, model soups) into a coherent pipeline whose modular design is a strength. The core experimental evidence shows the approach works well on 3/4 datasets and is fast. However, the incomplete comparison against Cold PAWS's full pipeline undermines the central claim of outperforming the state-of-the-art, and the unsubstantiated information-leakage accusation detracts from scholarly rigor. These issues are addressable but prevent acceptance in the current form. The paper would be a stronger contribution after revisions that fix the comparison protocol and clean up the presentation inconsistencies.

MY FINAL SCORE: <pineapple>5.5</pineapple>
MY FINAL DECISION: <orange>Reject</orange>